100 Results for "

PD-1/PD-L1 inhibitory peptide C8

" in MedChemExpress (MCE) Product Catalog:
Products (100)

100 Results for "PD-1/PD-L1 inhibitory peptide C8" in MCE Product Catalog:

Cat. No.: HY-P10826
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1/PD-L1 inhibitory peptide C8 is inhibits PD-1/PD-L1 interaction, promotes the activation of CD8+ and CD4+ T cells, and increases the IFN-γ secretion. PD-1/PD-L1 inhibitory peptide C8 exhibits antitumor efficacy in mouse model .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0276
CAS No.: 100040-31-1
Synonyms: Gastric inhibitory peptide (GIP), human
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP, human, a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP, human acts as an incretin hormone released from intestinal K cells in response to nutrient ingestion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P3400
CAS No.: 887255-16-5
Synonyms: LQVTDSGLYRCVIYHPP
Target:  

Inhibitory Antibodies

Research Areas:  

Neurological Disease

LP17 (LQVTDSGLYRCVIYHPP) is a BBB-penetrable triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide. LP17 substantially alleviates ischemia-induced infarction and neuronal injury. LP17 can get access into brain and block TREM-1 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0276A
Synonyms: Gastric inhibitory peptide (GIP), human TFA
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP, human TFA, a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP, human TFA acts as an incretin hormone released from intestinal K cells in response to nutrient ingestion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P3400A
Synonyms: LQVTDSGLYRCVIYHPP TFA
Target:  

Inhibitory Antibodies

Research Areas:  

Neurological Disease

LP17 (LQVTDSGLYRCVIYHPP) TFA is a BBB-penetrable triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide. LP17 TFA substantially alleviates ischemia-induced infarction and neuronal injury. LP17 TFA can get access into brain and block TREM-1 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0214A
Target:  

CaMK Autophagy

Research Areas:  

Neurological Disease

Autocamtide-2-related inhibitory peptide (TFA) is a highly specific and potent inhibitor of CaMKII with an IC50 of 40 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W012479
CAS No.: 153-94-6
Synonyms: D-Tryptophan
H-D-Trp-OH (D-Tryptophan) is the D-isomer of tryptophan, which is occasionally found in natural peptides, such as marine toxin peptides. H-D-Trp-OH can increase intestinal microbial diversity and counteract the inhibitory effect of allergic airway inflammation on intestinal microbial diversity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P10086
CAS No.: 1289375-12-7
Synonyms: Human TREM-1(213-221)
TREM-1 inhibitory peptide GF9 (Human TREM-1 (213-221)) is a TREM-1 inhibitor. TREM-1 inhibitory peptide GF9 blocks the TREM-1 signaling pathway via a ligand-independent mechanism, spontaneously inserts into the cell membrane to dissociate TREM-1 from DAP-12, and functions through the Signaling Chain Homooligomerization (SCHOOL) model. TREM-1 inhibitory peptide GF9 reduces the levels of TNFα, IL-1β, IL-6, and M-CSF. TREM-1 inhibitory peptide GF9 inhibits tumor growth, prolongs the survival of mice with pancreatic cancer models, ameliorates collagen-induced arthritis, and exerts protective effects on bone and cartilage simultaneously. TREM-1 inhibitory peptide GF9 can be used in research related to arthritis, pancreatic cancer, retinopathy, alcoholic liver disease, and liver cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1369
CAS No.: 251634-22-7
Target:  

Dynamin

Research Areas:  

Neurological Disease

DynaMin inhibitory peptide, myristoylated is a DynaMin inhibitor to interfere with the binding of amphiphysin with dynamin. DynaMin inhibitory peptide, myristoylated is a membrane-permeant form of the peptide that prevents endocytosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1083
CAS No.: 251634-21-6
Target:  

Dynamin

Research Areas:  

Neurological Disease

Dynamin inhibitory peptide competitively blocks binding of dynamin to amphiphysin, thus preventing endocytosis. Dynamin inhibitory peptide blocks the dopamine D3 effect on GABAA receptors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P5521
CAS No.: 3033299-76-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cardiovascular Disease

mLR12 is a Trem1 inhibitory peptide. mLR12 decreases aortic rupture rate in BAPN-induced Thoracic aortic aneurysm and dissection (TAAD) mice model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1138
CAS No.: 1315378-72-3
Synonyms: FSVYWAQADR
Research Areas:  

Others

Scrambled 10Panx (FSVYWAQADR) is an inactive scrambled control peptide of the Pannexin-1 hemichannel inhibitory peptide 10panx .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1138A
Synonyms: FSVYWAQADR TFA
Research Areas:  

Others

Scrambled 10Panx TFA (FSVYWAQADR TFA) is an inactive scrambled control peptide of the Pannexin-1 hemichannel inhibitory peptide 10panx .
loading...
    loading...
Cat. No.: HY-P10476
CAS No.: 1621169-52-5
Target:  

TGF-beta/Smad

Research Areas:  

Others

Myostatin inhibitory peptide 2 (compd 2) is a myostatin inhibitor with a Kd of 35.9 nM. Myostatin inhibitory peptide 2 can be used for researches of muscle atrophic disorders .
loading...
    loading...
Cat. No.: HY-P3579
CAS No.: 11063-17-5
Synonyms: GIP (1-42), porcine
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Gastric Inhibitory Peptide (GIP (1-42)), porcine is a porcine glucose-dependent insulinotropic polypeptide and inhibitor of pentagastrin-stimulated gastric acid secretion. Gastric Inhibitory Peptide, porcine stimulates endogenous somatostatin release. Gastric Inhibitory Peptide, porcine acts in a dose- and time-dependent manner in conscious, chronic gastric fistula-equipped rats .
loading...
    loading...
Cat. No.: HY-P0322
CAS No.: 111119-28-9
Synonyms: EMD 56574
Target:  

Integrin

GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption .
loading...
    loading...
Cat. No.: HY-W008876
CAS No.: 201531-88-6
Research Areas:  

Others

Fmoc-Pen(Trt)-OH is an amino acid derivative with an Fmoc protecting group that can be used to synthesize the inhibitory cystine knot (ICK) peptide ProTx-II .
loading...
    loading...
Cat. No.: HY-P11271
CAS No.: 2940971-65-1
Research Areas:  

Metabolic Disease

Ribupatide is a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. Enicepatide can be studied in antidiabetic research .
loading...
    loading...
Cat. No.: HY-P10242
CAS No.: 1621169-56-9
Target:  

TGF-beta/Smad

Research Areas:  

Others

Myostatin inhibitory peptide 7 is a 23 amino acids peptide, which is derived from amino acids 21 to 43 of the mouse myostatin prodomain. Myostatin inhibitory peptide 7 inhibits myostatin with a Kd of 29.7 nM. Myostatin inhibitory peptide 7 can be used for researches of muscle atrophic disorders .
loading...
    loading...
Cat. No.: HY-P10089
Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

TREM-1 inhibitory peptide M3 is a ligand-dependent TREM-1 antagonist. TREM-1 inhibitory peptide M3 can inhibit systemic and pulmonary pro-inflammatory cytokine and chemokine production and attenuate acute lung injury .
loading...
    loading...